mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.5 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.5 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |